6MK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Merck & Co Inc

Watchlist Manager

Watchlist

Price: 96.79 EUR -0.03% Market Closed

Market Cap: €157.5B

M	Merck & Co Inc XHAM:6MK	US
M	MEI Pharma Inc F:MMIA	US
N	Novo Nordisk A/S XMUN:NOVA	DK
A	Abercrombie & Fitch Co SWB:AFT	US
A	Activision Blizzard Inc F:AIY	US
D	Duke Energy Corp SWB:D2MN	US
	Valiant Holding AG LSE:0QPU	CH
B	Baker Hughes Co NASDAQ:BKR	US
	Premia SA F:3FDA	GR
A	Anglo American PLC F:NGLB	UK
C	Carrefour SA XMUN:CAR	FR
B	Basf Se XHAM:BAS	DE

Profitability Summary

Merck & Co Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

76%

Gross Margin is Increasing

73% > 78%

Healthy Operating Margin

25%

Strong 3Y Average Operating Margin

36%

Declining Operating Margin

34% > 25%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

23% > 14%

Exceptional Free Cash Flow Margin

19%

Strong 3Y Average Free Cash Flow Margin

21%

Declining Free Cash Flow Margin

19% > 19%

Positive ROE

18%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

18% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.